by Co-Diagnostics | Sep 1, 2020 | Market Update, News Release
Salt Lake City, Utah – September 1, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, issued the following statement concerning the progress of the...
by Co-Diagnostics | Apr 20, 2020 | Market Update
Salt Lake City, Utah – April 20, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that Company COVID-19 test sales in the United States have continued...
by Co-Diagnostics | Nov 8, 2019 | Market Update
Following recent Company news of expansion into Africa with the sale and installation to one of the largest private molecular diagnostics laboratories in Ghana, Co-Diagnostics, Inc. (Nasdaq: CODX), today issued a malaria in Africa fact sheet to accompany that release....
